Skip to content

Serotonin: all studies

Page 370 of 400: studies 3,691 to 3,700 of 3,999, newest first. Back to the serotonin overview

Research

Multiple molecular and neuropharmacological effects of MDMA (Ecstasy).

Life Sciences January 2, 2004 Rabi Simantov

3,4-Methylenedioxymethamphetamine (MDMA), commonly referred to as Ecstasy, is a widely abused, psychoactive recreational drug, which induces short- and long-term neuropsychiatric behaviors. This drug is neurotoxic to serotonergic neurons in vivo, and induces programmed cell death in cultured human serotonergic cells and rat neocortical neurons. Over the years it has been shown that MDMA alters...

Depersonalisation disorder: a contemporary overview.

CNS Drugs 2004 Daphne Simeon

Depersonalisation disorder is characterised by prominent depersonalisation and often derealisation, without clinically notable memory or identity disturbances. The disorder has an approximately 1 : 1 gender ratio with onset at around 16 years of age. The course of the disorder is typically long term and often continuous. Mood, anxiety and personality disorders are often comorbid with...

Trip, speed et taz

Psychotropes 2004 Christian Sueur 1 citation

De quoi s'agit-il ?De trois substances, de trois drogues synthétiques interdites au coeur du discours sur les fêtes technos, et de leur persécution par les pouvoirs en place, mais trois substances vieilles comme le monde, trois substances magiques… Trip, « voyage », le diéthylamide de l'acide lysergique, le LSD-25, 25°c omposé synthétisé en 1943 par Albert Hofmann 1 , à partir de dérivés de...

Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography

Neuropsychobiology 2004 Jordi Riba, P. Anderer, F Jané et al. 131 citations

<i>Ayahuasca,</i> a South American psychotropic plant tea obtained from <i>Banisteriopsis caapi</i> and <i>Psychotria viridis</i>, combines monoamine oxidase-inhibiting β-carboline alkaloids with N,N-dimethyltryptamine (DMT), a psychedelic agent showing 5-HT<sub>2A</sub> agonist activity. In a clinical research setting, <i>ayahuasca</i> has demonstrated a combined stimulatory and psychedelic...

DOI: 10.1159/000077946 (opens in new tab) Ayahuasca Hallucinogen Electroencephalography Neuroimaging +1

Neuroimagen y neurotoxicidad inducida por MDMA (éxtasis)

Adicciones December 15, 2003 Una D. Mccann, George A. Ricaurte

El incremento del consumo de éxtasis (MDMA) por parte de los jóvenes ha obligado al estudio de efectos a corto y medio plazo sobre el SNC. En la última década, se demostró la existencia de neurotoxicidad serotoninérgica en el SNC. Recientemente aparecieron estudios tendentes a demostrar también daño dopaminérgico que se ha evidenciado en experimentación animal. Las diferentes técnicas de...

LSD y alucinógenos

Adicciones December 15, 2003 Josep Solé Puig 1 citation

Objetivo: realizar una revisión del LSD y otros alucinógenos desde un punto de vista histórico-cultural, farmacológico y de consecuencias clínicas, especialmente psiquiátricas. Resultados: datos aportados por el PNSD ponen de manifiesto que más del 2% de la población española reconoce haber consumido esta sustancia, que ejerce su acción a través de los sistemas de neurotransmisión...

Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy).

Brain Research October 17, 2003 Neil Easton, Jeff Fry, Esther O'Shea et al.

Administration of 3,4-methylenedioxymethamphetamine (MDMA) or 3,4-methylenedioxyamphetamine (MDA) to rats produces serotonergic nerve terminal degeneration. However, they are not neurotoxic when injected directly into the brain, suggesting the requirement for peripheral metabolism of MDMA to a neurotoxic metabolite. Alpha-methyldopamine (alpha-MeDA) is a major metabolite of MDA. There are...

Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex

Journal of Neuroscience October 1, 2003 Javier González-Maeso, Tony Yuen, Barbara J. Ebersole et al. 295 citations

Most neuropharmacological agents and many drugs of abuse modulate the activity of heptahelical G-protein-coupled receptors. Although the effects of these ligands result from changes in cellular signaling, their neurobehavioral activity may not correlate with results of in vitro signal transduction assays. 5-Hydroxytryptamine 2A receptor (5-HT2AR) partial agonists that have similar...

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Pharmacological Reviews September 2003 Alfred Richard Green, Annis O. Mechan, J Martin Elliott et al.

The amphetamine derivative (+/-)-3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popular recreational drug among young people, particularly those involved in the dance culture. MDMA produces an acute, rapid enhancement in the release of both serotonin (5-HT) and dopamine from nerve endings in the brains of experimental animals. It produces increased locomotor activity and the serotonin...

Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA ('Ecstasy') and p-chloroamphetamine in mice.

Nitric oxide : biology and chemistry August 2003 Karen L. Anderson, Yossef Itzhak

Repeated exposure to psychostimulants such as cocaine and amphetamines results in behavioral sensitization, a paradigm thought to be relevant to drug craving and addiction in humans. We have previously shown that the induction, expression, and maintenance of psychomotor sensitization to cocaine, methamphetamine, and methylphenidate (indirect dopamine agonists) are blocked by co-administration...